You need to be logged in to view this video
Kineta, Inc.--Developing Novel Immunotherapies to Transform Patients' Lives
Released on Thursday, November 5, 2020•BIOTECH
Dr. Shawn Iadonato, CEO of Kineta, Inc., will discuss the clinical stage biotechnology company committed to developing disruptive life science technologies that address unmet patient needs especially for patients with cancer. Kineta, Inc., has leveraged expertise in immunology to advance a focused pipeline of investigational drugs in oncology, neuroscience, and virology.
Filter By Category
Filter By Keywords